Midwest Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$288K Buy
3,340
+889
+36% +$79K ﹤0.01% 549
2026
Q2
$222K Sell
2,451
-693
-22% -$58.1K ﹤0.01% 584
2026
Q1
$252K Sell
3,144
-224
-7% -$18.5K ﹤0.01% 543
2025
Q4
$287K Sell
3,368
-14
-0.4% -$1.15K ﹤0.01% 517
2025
Q3
$263K Buy
3,382
+14
+0.4% +$1.09K ﹤0.01% 530
2025
Q2
$263K Buy
+3,368
New +$251K ﹤0.01% 540

Other funds holding EW

Midwest Trust's EW Position: Q3 2026 in Review

Midwest Trust increased its Edwards Lifesciences (EW) stake by 36% in Q3 2026, buying an estimated $79K and bringing the position to 3,340 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Midwest Trust first reported a position in EW in Q2 2025 and has held it in 6 quarters since. 325 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Midwest Trust held 3,340 shares of Edwards Lifesciences worth $288K as of Q3 2026.
  • Midwest Trust bought 889 Edwards Lifesciences shares in Q3 2026, an estimated $79K.
  • Edwards Lifesciences made up ﹤0.01% of Midwest Trust's portfolio in Q3 2026, its #549 holding.
  • Midwest Trust first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 6 quarters since.
  • 325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Midwest Trust's 13F filing for Q3 2026, filed 22 Oct 2026.